(Q27851787)

English

A molecularly annotated platform of patient-derived xenografts ("xenopatients") identifies HER2 as an effective therapeutic target in cetuximab-resistant colorectal cancer.

scientific article

Statements

A molecularly annotated platform of patient-derived xenografts ("xenopatients") identifies HER2 as an effective therapeutic target in cetuximab-resistant colorectal cancer. (English)
1 reference
0 references
0 references
0 references
0 references
0 references
0 references
0 references
0 references
Giorgia Migliardi
0 references
Francesco Galimi
0 references
Francesco Sassi
0 references
Davide Torti
0 references
Davide Corà
0 references
Michela Buscarino
0 references
Dario Ribero
0 references
Nadia Russolillo
0 references
Andrea Muratore
0 references
Paolo Massucco
0 references
Alberto Pisacane
0 references
Luca Molinaro
0 references
Mauro Risio
0 references
Lorenzo Capussotti
0 references
Marcello Gambacorta
0 references
Livio Trusolino
0 references
November 2011
0 references
1
0 references
508-23
0 references
6
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit